EWTX Edgewise Therapeutics, Inc.

NASDAQ

$40.48

Edgewise Therapeutics, Inc. (EWTX) Earnings News

Earnings press releases, previews and reviews for Edgewise Therapeutics, Inc. (EWTX), newest first.

Thursday August 6, 2026 8:00 AM ET

Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

Tuesday June 16, 2026 7:00 AM ET

Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

Thursday May 7, 2026 8:00 AM ET

Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications